Coagulation factors II, V, VII, IX, X and XI and mortality – a cohort study
10.1016/j.rpth.2023.102193
Saved in:
Main Authors: | Yap, ES, Lijfering, WM, Rosendaal, FR, Cannegieter, SC |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
Elsevier BV
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/245611 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Use of activated recombinant factor VII in severe bleeding - Evidence for efficacy and safety in trauma, postpartum hemorrhage, cardiac surgery, and gastrointestinal bleeding
by: Iau, P., et al.
Published: (2014) -
Anticoagulation and monitoring of a novel and reversible factor IXa inhibitor
by: Becker, R.C., et al.
Published: (2016) -
Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study.
by: Yap, Eng Soo, et al.
Published: (2023) -
Association of factor VII genotype with plasma factor VII activity and antigen levels in healthy Indian adults and interaction with triglycerides
by: Saha, N., et al.
Published: (2013) -
HEDGING STRATEGIES BY JUDGING PANELS IN TWO REALITY SHOWS: X–FACTOR VIETNAM AND X-FACTOR US = Chiến lược rào đón được sử dụng bởi ban giám khảo trong hai chương trình truyền hình thực tế: X–Factor Việt Nam và X-Factor Mỹ
by: Phạm, Thị Linh
Published: (2020)